Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.3 HKD | -0.18% | +0.53% | +11.66% |
May. 27 | New China Life Insurance Declares 2023 Year-End Dividend | MT |
May. 22 | Nomura Adjusts China Life Insurance’s Price Target to 19.93 Yuan From 17.80 Yuan, Keeps at Reduce | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.66% | 100B | B- | ||
+4.52% | 101B | B | ||
-14.25% | 84.31B | B+ | ||
+19.42% | 74.31B | D+ | ||
+19.05% | 34.25B | B | ||
+18.22% | 30.7B | B | ||
-0.47% | 17.31B | C+ | ||
-12.95% | 14.31B | B | ||
+19.08% | 12.73B | A- | ||
+6.83% | 9.73B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 2628 Stock
- Ratings China Life Insurance Company Limited